Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001604867-25-000009
Filing Date
2025-05-15
Accepted
2025-05-15 11:17:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8245
2 sls_ex1_20250515.pdf EX-1 47904
  Complete submission text file 0001604867-25-000009.txt   76223
Mailing Address 1063 POST ROAD 2ND FLOOR DARIEN CT 06820
Business Address 1063 POST ROAD 2ND FLOOR DARIEN CT 06820 203-625-1300
Solas Capital Management, LLC (Filed by) CIK: 0001604867 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Subject) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94252 | Film No.: 25950101
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)